<DOC>
	<DOCNO>NCT00004331</DOCNO>
	<brief_summary>OBJECTIVES : I . Characterize enzyme defect patient know suspected porphyria family member . II . Determine whether select patient eligible porphyria research protocol . III . Provide blood , urine , fecal sample well characterized patient family member investigator study nature specific mutation gene heme biosynthetic pathway enzyme .</brief_summary>
	<brief_title>Studies Porphyria I : Characterization Enzyme Defects</brief_title>
	<detailed_description>PROTOCOL OUTLINE : All patient evaluate porphyria type factor contribute clinical expression particular form disease . Testing include erythrocyte porphobilinogen deaminase , erythrocyte protoporphyrin , plasma porphyrin , urinary fecal porphyrin precursor . Selected patient enter porphyrin research protocol institution , include analysis DNA identify specific mutation gene heme biosynthetic pathway enzyme .</detailed_description>
	<mesh_term>Porphyrias</mesh_term>
	<mesh_term>Porphyria , Erythropoietic</mesh_term>
	<criteria>Suspected confirm porphyria Adults , child , family member eligible</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2003</verification_date>
	<keyword>inborn error metabolism</keyword>
	<keyword>porphyria</keyword>
	<keyword>rare disease</keyword>
</DOC>